Oxurion NV
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Oxurion NV
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group’s research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.
/ 
Frequently asked questions
To buy Oxurion NV stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Oxurion NV by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Oxurion NV is OXUR:xbru. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Oxurion NV has its primary listing on Euronext Brussels. You can trade Oxurion NV with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Oxurion NV is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Oxurion NV as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Oxurion NV.